Investors holding Vanguard S&P 500 ETF (NYSEARCA:VOO) own a slice of the cheapest, largest cap-weighted index fund on the market, and it has been doing its job. VOO is up 10.25% year-to-date through July 7, 2026, riding a benchmark that continues to be dominated by mega-cap technology. The pitch to swap VOO for the Pacer US Cash Cows 100 ETF (COWZ) rests on a simple idea: screen the Russell 1000 for the highest free-cash-flow yields and buy the top 100 names, weighted by trailing FCF. That approach has attracted $18.18 billion in net assets and produced real outperformance in earlier cycles. The question is whether the trade actually works in 2026.
Structural Differences in Holdings
This cash-focused strategy owns 127 positions, concentrated in businesses trading at attractive multiples of free cash flow. Current top holdings look nothing like the typical leaderboard.
Qualcomm is at 2.67%, Altria at 2.20%, ConocoPhillips at 2.17%, CVS Health at 2.16%, and Bristol-Myers Squibb at 2.03%. Energy names collectively make up roughly an eighth of the fund, and there is a notable absence of major tech firms like Apple, Microsoft, Nvidia, Alphabet, Meta, or Tesla in the top slots. This is the core of the strategy, as it aims to skip crowded mega-caps in favor of proven cash generators at lower prices, in sharp contrast to the broader index’s tech-heavy tilt.
Comparative Performance and Fee Analysis
The premise that a cash-cow screen is beating the market this year does not hold up against the actual numbers. The S&P 500 index is up 10.25% YTD, while the cash-cows fund is up 7.28% YTD, a gap of nearly three percentage points in favor of the benchmark. One-year results tell the same story, with the market index returning 21.86% versus 16.66% for the cash-flow strategy. The five-year return gap widens even further to 86.16% against 67.19%.
Fees also widen the gap. The benchmark fund charges 0.03%, while the factor-based alternative charges 0.49%. This 0.46-percentage-point drag compounds annually. Over a decade on a $100,000 position, the fee differential alone equals roughly $4,600 of foregone value before considering performance, making the strategy’s hurdle for success much higher.
Concentration and Market Risks
Diversification across 519 holdings provides the broad index fund with stability. The cash-cows fund has 127 positions capped near 2.67% each, yet sector exposure can run up to 40% after quarterly rebalances.
Recent coverage noted that a 23% allocation to Energy was a primary reason for the strategy’s post-2024 lag. Rising capital expenditures in Energy and Pharma, flagged in June 2026 reports, can also compress the trailing FCF metric the index uses to rank names, potentially creating a drag on the fund’s internal selection criteria.
Single-name risk is higher in the more concentrated basket. This means the impact of sector-specific headwinds, such as the volatility seen in energy cycles, is far more pronounced here than in a broad index.
Strategic Allocation and Tax Implications
Choosing a path forward requires evaluating whether the strategy is being purchased for what it has done, or for what future conditions might dictate. Taxable accounts face the additional burden of selling appreciated shares to fund a purchase that is currently trailing on cost, YTD return, and long-term performance.
While the factor fund carries a 2.06% trailing dividend yield, well above the 1.07% yield of the broad index, and a lower price-to-earnings profile, the 2026 price data has yet to show value leadership. The 10Y-2Y Treasury spread has compressed from 0.74% in February to 0.35%, an environment some strategists associate with value leadership, but price action has not confirmed this shift yet.
A partial allocation, perhaps 5% to 10% of an equity sleeve, provides exposure to the FCF-yield factor without abandoning the low-cost core. A full swap based on a 2026 outperformance narrative is not supported by the numbers currently available.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks